Disruption of FKBP3 significantly increases the resistance of A. flavus to rapamycin and FK506.
(A) Phenotype of A. flavus WT and all mutant strains (ΔFKBP1, ΔFKBP2, ΔFKBP3 and ΔFKBP4) grown on PDA amended with 100 ng/mL rapamycin at 37°C for 5 days.
(B) TLC assay of AFB1 production by the WT and all mutant strains (ΔFKBP1, ΔFKBP2, ΔFKBP3 and ΔFKBP4) cultured in YES liquid medium at 29°C for 6 days.
(C) The growth inhibition rate of the WT and all mutant strains (ΔFKBP1, ΔFKBP2, ΔFKBP3 and ΔFKBP4) under rapamycin stress.
(D) AFB1 quantitative analysis of the WT and all mutant strains (ΔFKBP1, ΔFKBP2, ΔFKBP3 and ΔFKBP4) described in (B).
(E) Phenotype of WT and all mutant strains (ΔFKBP3, K5A, K19A, K40A, K42A, K55A and K65A) grown on PDA amended with 100 ng/mL rapamycin at 37°C for 5 days.
(F) The growth inhibition rate of WT and all mutant strains (ΔFKBP3, K5A, K19A, K40A, K42A, K55A and K65A) under rapamycin stress.
(G) TLC assay of AFB1 production by the WT and all mutant strains (ΔFKBP3, K5A, K19A, K40A, K42A, K55A and K65A) cultured in YES liquid medium at 29°C for 6 days.
(H) Relative quantification of AFB1 production in WT and all mutant strains (ΔFKBP3, K5A, K19A, K40A, K42A, K55A and K65A) as mentioned in (G).